At the end of the latest market close, Titan Pharmaceuticals Inc. (TTNP) was valued at $0.13. In that particular session, Stock kicked-off at the price of $0.1254 while reaching the peak value of $0.14 and lowest value recorded on the day was $0.125. The stock current value is $0.14.
Recently in News on November 16, 2020, Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today reported financial results for the third quarter ended September 30, 2020 and provided an update on its business. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Titan Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.5450 on 03/03/20, with the lowest value was $0.0940 for the same time period, recorded on 11/06/20.
Titan Pharmaceuticals Inc. (TTNP) full year performance was -15.96%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Titan Pharmaceuticals Inc. shares are logging -74.29% during the 52-week period from high price, and 49.04% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.09 and $0.55.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 24783200 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Titan Pharmaceuticals Inc. (TTNP) recorded performance in the market was -34.62%, having the revenues showcasing -50.47% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 24.31M, as it employees total of 21 workers.
Market experts do have their say about Titan Pharmaceuticals Inc. (TTNP)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2132, with a change in the price was noted -0.1647. In a similar fashion, Titan Pharmaceuticals Inc. posted a movement of -53.79% for the period of last 100 days, recording 14,310,364 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TTNP is recording 3.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.06.
Technical breakdown of Titan Pharmaceuticals Inc. (TTNP)
Raw Stochastic average of Titan Pharmaceuticals Inc. in the period of last 50 days is set at 30.31%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 30.31%. In the last 20 days, the company’s Stochastic %K was 23.17% and its Stochastic %D was recorded 18.91%.
Bearing in mind the latest performance of Titan Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -34.62%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -51.19%, alongside a downfall of -15.96% for the period of the last 12 months. The shares increased approximately by 3.34% in the 7-day charts and went down by 7.72% in the period of the last 30 days. Common stock shares were lifted by -50.47% during last recorded quarter.